This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

I have bought in this morning ahead of Tuesdays meeting I expect 250p if the news is as good as say it is..especially if there is talk of a tie-up sometime this year.

It's going up, looking good to me.

MS

I always thought that was the game plan, develop the drugs early on in trials and flog them to a big pharma for further development. The Bears would have you beleive that this is not the case but I can rember Best stating this a few years back now.

cheers GF.

Thats where the shorters got it wrong gf as DB will sell to a big pharma at the end of phase 2 rather than phase 3 and that could be sooner than most people think.

Any idea how soon mitzy. Are we talking say 2-3 months or longer. Any guidance would be appreciated.

MS

mickey:reckon we will have to wait till tommorow but would have thought at least 6 months.

OK thanks for that mitzy.

MS

From the other place. Some good postings today. Makes a change, although the guys that post on MMG are good and sensible.

469514 - 25 Apr'05 - 09:35 - 5222 of 5223


Michael Walters says in his site that there will certainly not be any price sensitive new information issued in tomorrow's presentation, and he does seem to to talk to David Best a lot. So we shouldn't build up expectations. However the shares may still get propelled upwards from a wider media knowledge about what is going on.

It is very clear to me, from a close study of the Walter's articles and some emails from Mr Best, that Genvax could be a huge breakthrough in cancer treatment. And yet the press do not seem to have picked up even a whiff of this excitement.

There is only a relatively small number of people aware of the superb potential here and it demonstrates to me, again, the value of sensible buletin board discussion that we often get on here. The presentations will inevitably have to be cautious at this stage but if the press can get a sense of Best's enthusiasm and see through to the underlying message in the test results then we could see quite a dramatic re-rating of the shares.

At first sight, Benny's predictions do look somewhat extravagant, but if everything goes well I think he could be right.

Nothing can be certain in this sector of investment and there have indeed been numerous disappointments with late stage drug trials in the past. "They said the same thing about British Biotech" is often heard from the sceptics. But one day a company will hit the jackpot and imho, MMG looks like one of the likliest candidates to do just this.

Xylos

MS

If anyone's shorting these they are going to get stuffed.

MS

So we are talking early May again for Ruthenium results. Ah whats in a few days, no problem.

For MMG to put out a RNS re- to the Broadcast makes me feel that there could be some price sensitive information even if its not on the ruthenium.

cheers GF.

Well its finally broken out of the 170p to 200p level and I expect further rises to 240p if Tuesdays news is positive.

One as to ask why put out a RNS if theres going to be no price sensitive information?????????????????????????????????????????????????????????.

They could just bang it on their web site that the presentation is going to be made.

Anyway I see the price is rocking on now. Taking all those profits of Evils away the nearer it gets to 250p.

cheers GF.

Another move up, a sea of blue, NICE.

cheers GF.

He's too canny to get caught on this one. I expect he's reversed his position.

MS

I would have thought he closed a week ago or else he has lost a bundle.
Notice the 50K T trade a shorter closing perhaps.

Might be Evil getting rid of his last few.

cheers GF.

If this goes back up to 250+ do you think the shorters will return?

MS

I suspect that buyers will return as the sp steadily increases to 240p and that there will be new buyers coming in pushing the sp back to 300p.

mitzy what would your realistic price estimate be if a big pharma did move in.

Gone in again at 211p.

cheers GF.